Ultragenyx Pharmaceutical: Clinical Trials & Research Profile

Biopharma Industry (Global / Institutional) · Primary Focus: Rare Genetic, Women's Health, and Other

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Global / Institutional)
Primary Therapeutic AreaRare Genetic, Women's Health, and Other
Active Phase II & III Studies8 active (2 recruiting now)
Total Tracked Studies (2018 to 2026)17 (11 with California sites)
Completed vs Early-Stopped Studies3 completed / 6 stopped (35.3% stop rate)
Median Closed Enrollment54 participants
FDA Drugs@FDA Original Approvals0 all-time (0 from 2018 to 2026)
Physical Hospital Site Disclosure100.0% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Ultragenyx Pharmaceutical across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk